In Vitro and In Vivo Models to Assess the Immune-Related Effects of Nanomaterials
The immunological safety of drugs, nanomaterials and contaminants is a central point in the regulatory evaluation and safety monitoring of working and public places and of the environment. In fact, anomalies in immune responses may cause diseases and hamper the physical and functional integrity of l...
Guardado en:
Autores principales: | Diana Boraschi, Dongjie Li, Yang Li, Paola Italiani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a792537d2fdf44778fe9a6b51f74b259 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparisons of in vitro Fick’s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS
por: Ye J, et al.
Publicado: (2019) -
Assessing Intestinal Health. In Vitro and Ex vivo Gut Barrier Models of Farm Animals: Benefits and Limitations
por: Federico Ghiselli, et al.
Publicado: (2021) -
In vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease
por: Martin Borch Jensen, et al.
Publicado: (2021) -
Corrigendum: In Vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease
por: Martin Borch Jensen, et al.
Publicado: (2021) -
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
por: Mariana Matias, et al.
Publicado: (2021)